Introduction

Meningococcal disease is a very serious, sometimes fatal infection by the bacterium Neisseria meningitidis. This would further cause meningitis, septicemia, and damage to the brain, spinal cord, and blood. Considering this is a fast-moving disease with devastating consequences, prevention becomes of the essence. Meningococcal prophylaxis is the technique used which can assist in preventing the spread of this disease. It requires vaccination, as well as prophylactic antibiotic treatment, of close contacts of infected persons. This essay guards the rights to the need for meningococcal prophylaxis by proposing the major ways of protecting oneself and others from this dangerous pathogen.

What Is Meningococcal Disease?

Meningococcal disease is caused by the bacterium Neisseria meningitidis. It can lead to life-threatening conditions such as meningitis-which is an inflammation of the protective membranes called meninges surrounding your brain and spinal cord-and septicemia bloodstream infection. The mode of transmission includes respiratory droplet or direct contact, such as kissing, coughing, sneezing; or sharing food, drinks, utensils, etc., with an infected person. Early signs tend to resemble the flu but include a fever, headache, and stiff neck, while it rapidly escalates to serious symptoms such as confusion, sensitivity to light, and rash. This biological agent causes very serious and very rapidly progressing diseases leading to death, or it causes permanent disabilities like brain damage, hearing loss, and arm or limb amputation within hours if it is not quickly treated. Vaccination is the best prevention, especially for individuals at increased risk, as well as prompt antibiotic treatment for infected people. Prophylactic antibiotics may be necessary if one has had close contact with infected individuals to prevent further spread.

What Is the Need for Meningococcal Prophylaxis?

Meningococcal prophylaxis is the immunization against Neisseria meningitidis, which is the bacterium that causes meningococcal infection or meningococcal disease, characterized also by meningitis besides septicemia. A number of reasons make them indications of the prophylaxis:

• Prevention of Secondary Cases: In the case of an infected family member, roommates and health personnel, meningococcal disease can suddenly be transmitted to close contacts. Prophylaxis will minimize the risk of transmission.

• High Morbidity and Mortality: Meningococcal infections are accompanied by high morbidity; the sequelae may range from brain damage, hearing loss, and sometimes death. Preventive measures against the infection reduce these serious outcomes.

• Rapid Disease Progression: The disease caused by meningococcus progresses rapidly; it often develops in hours. Prophylaxis is hence required early to prevent disease in contacts.

• Community Outbreak: Another clue for providing prophylaxis is indicated by community outbreaks of meningococcal infection, for example, schools and dormitories, which provide an opportunity for controlling such community outbreaks. It primarily protects vulnerable populations, which include the most frequently affected persons: children and their teenagers, as well as persons with specific medical conditions. In this context, prophylaxis protects those categories of persons.

• Low-Cost: Though expensive in the treatment of the disease by using prophylaxis, treating the disease with prophylaxis is less costly than treating severe cases and managing the complications arising from it for years.

• Public Health Policy: Prophylaxis remains a critical aspect of public health policy that controls and addresses outbreaks of meningococcal disease.

What Are the Different Kinds of Vaccines Available for Meningococcal Prophylaxis?

There are several vaccines available today against different serogroups of Neisseria meningitidis that can be used in the prophylaxis of meningococcal infections. The different kinds of immunity developed by these vaccines against specific bacterial serogroups prevent the disease caused by this bacterium. Among the major kinds of vaccines available for meningococcal prophylaxis are:

• MenACWY - conjugate vaccines that protect against four serogroups. A, C, W, and Y. They are mainly Menactra, Menveo, and Nimenrix. They are often administered to adolescents, individuals traveling to endemic regions, and others suffering from a type of medical ailment.

• They also are the cause of most cases during epidemics among teens and young adults, like the other serogroup B vaccines, including Bexsero and Trumenba. The latter also is recommended for persons with conditions that place them at increased risk for infections caused by serogroup B, including during outbreaks.

• MenA vaccines or Monovalent vaccines are meningococcal vaccines against serogroup A. They are mainly employed in Africa's "meningitis belt." So far, they have proved very effective in preventing major outbreaks within the area.

• Combination vaccines incorporate a few vaccines that combine meningococcal vaccines with other vaccines. Example: MenHibrix, a vaccine against meningococcal and Haemophilus influenzae type b.

• Polysaccharide vaccines are older vaccines, like Menomune, protecting against serogroups A, C, W, and Y. They are less in use compared to others due to lower immunogenicity among the younger age groups.

What Are the Contraindications for Meningococcal Vaccines?

Contraindications of meningococcal vaccines are specific conditions where the vaccine should not be given because of the potential risks involved. Key contraindications to the vaccine include the following:

• Anaphylaxis: Vaccines should not be given to anyone with a history of anaphylaxis after a previous dose of meningococcal vaccine or to any component of the vaccine. Hypersensitivity to vaccine components, a known hypersensitivity to one or more components of the vaccine- for instance, diphtheria toxoid used in conjugate vaccines-is a contraindication to vaccination.

• Acute Disease: Vaccination should be postponed in the presence of an acute or severe febrile illness until the patient has recovered. This will prevent confounding any illness-related manifestations.

• Pregnancy and Lactation: Use of some of the meningococcal vaccines in pregnancy and lactation is not an absolute contraindication but rather an individual risk-versus-benefits consideration.

• History of GBS: Some advisory warns against immunization of persons with a history of GBS, especially with the MenACWY vaccine.

• Children (Specified Age): Immunization less than the specified age is not approved. Example: MenB vaccines are not approved for children less than ten years old.

Conclusion

Meningococcal infection is a serious and highly-increasing infection that can cause fatal results. Prevention, including vaccination and antibiotic treatment for close contacts, should be given importance to prevent the dangerous spread of the disease. Otherwise, there is a very great possibility that severe complications, long-term disabilities, and death will result if preventive measures are not strictly followed. Understanding the importance of meningococcal prophylaxis gives people a chance to be responsible, taking measures that would protect themselves and others. In situations where the diseases are highly infectious, prevention is bound to be adopted in institutions such as schools and hostels to curb the spread of the diseases to other citizens.